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Received March 29, 2010; accepted June 22, 2010AbstractPrimary cancers of the external auditory canal (EAC) are rare and most are squamous cell carcinomas. We report the case of a 78-year-old
man who visited our institution with a 5-month history of right-side intermittent otalgia and ear fullness. Otoscopic examination showed
a bulging mass arising from the superior and posterior aspects of the right EAC, and incision biopsy confirmed the lesion as adenoid cystic
carcinoma (ACC). Lateral temporal bone resectionin conjunction with total parotidectomy and neck dissection was subsequently performed.
Postoperative adjuvant radiotherapy was administered and no recurrence was noted at a 26-month follow-up. We review the medical literature on
the topic and suggest that early diagnosis is still the best option for successful treatment of this neoplasm. ACC arising in the EACmust be
removed using radical procedures to increase the chance of local control. Subsequent metastasis that tends to develop in the lungs and regional
lymph nodes is best evaluated regularly using computed tomography examination.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Malignant tumors involving the external auditory canal
(EAC) and temporal bone are exceedingly rare, and the most
common type is squamous cell carcinoma.1 The presence of
adenoid cystic carcinoma (ACC) arising in the EAC is there-
fore infrequently encountered. ACC of the head or neck is
usually found in the salivary glands, oral cavity, palate, nasal
cavity, and nasopharynx.2 Since 1894, there have been only
106 cases of ACC involving the EAC reported the English
literature. The natural history of ACC of the EAC is charac-
terized by an indolent clinical course, which usually leads to
a late diagnosis. The treatment goal includes complete surgical
extirpation and a clear margin because of the high risk of repeat
local recurrence. It is not uncommon for distant metastasis,
mainly to the lungs, to occur over the course of many years.3,4* Corresponding author. Dr. Chih-HungWang, Department of Otolaryngologye
Head andNeck Surgery, Tri-ServiceGeneralHospital, 325, Section 2, Cheng-Kung
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doi:10.1016/j.jcma.2012.04.007Because of the rarity of ACC of the EAC, most of the
observations drawn from various reports lack detailed
comparisons of pathological findings and long-term outcome
follow-up. Here, we present our own case along with a review
and discussion of the literature to date.2. Case report
A 78-year-old man presented with a 5-month history of right-
side intermittent otalgia and ear fullness. His past history was
unremarkable. Otoscopic examination showed a bulging mass
with an irregular surface arising in the rightEAC (Fig. 1A).High-
resolution computed tomography (CT) of the temporal bone
showed an ill-defined, moderately enhanced, soft tissue mass
protruding from the superior and anterior walls of the EAC
(Fig. 1B), measuring 10 mm at the widest point, with adjacent
bone erosion. Incision biopsy confirmed the diagnosis of ACC.
Further information from magnetic resonance imaging (MRI)
with gadolinium suggested that the superficial lobe of the parotid
gland and the anterior portion of the temporal bone were alsohinese Medical Association. All rights reserved.
Fig. 1. (A) Subcutaneous mass bulging from the superior and posterior aspects of the external auditory canal (EAC). (B) Coronal computed tomography scan of the
temporal bone demonstrating a soft tissue mass (arrow) protruding from the superior wall of the EAC. (C) Magnetic resonance imaging shows that the superficial
lobe of the parotid gland (arrowhead) and the anterior portion of the temporal bone (arrow) may have been invaded by the mass lesion.
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the osseous EAC but had not invaded the middle ear cavity, and
based on a presumed clinical T3N0M0 stage using University of
PittsburghTNMstaging for EAC carcinoma,5,6 surgery entailing
lateral temporal bone resection in conjunction with total paroti-
dectomy and selective neck dissection levels IIII was per-
formed. In brief, the lateral temporal bone resection was
approached with a wide postauricular incision followed by
a separate incision made around the tragus and a portion of the
conchal cartilage to isolate the tumor from the normal auricle.
The facial nerve was skeletonized in its course through the sty-
lomastoid foramen up to the geniculate ganglion and was found
to be tumor-free. The malleuseincus joint was then dis-
articulated. The EAC, with the tumor lesion in its osseous and
cartilaginous parts, was completely isolated and removed en
bloc, along with the tympanic membrane and the ossicles
(Fig. 2). The defect left over the lateral temporal region was
reconstructed by rotation of the sternocleidomastoid (SCM)
muscle and temporalis muscle flap.
Histologically, the tumor cells were in sheets and showed
a predominantly cribriform pattern with scant intervening
stroma. The cells were basaloid, with a scanty cytoplasm and
hyperchromatic nuclei (Fig. 3). The lumina in the cribriform
areas contained material that was positive in a periodic acid
Schiff test. Few areas of necrosis were noted. Immunohisto-
chemistry analysis revealed intense and diffuse positive staining
for cytokeratin, vimentin, and muscle actin, and focal staining
for S-100 protein. These findings confirmed the diagnosis of
ACC of the EAC with perineural invasion and involvement of
the tympanic portion of the temporal bone. The parotid gland
and neck nodes were not invaded. Although clear surgical
margins were achieved, postoperative adjuvant radiotherapy
with doses of 6000 cGy in 34 fractions was administered. Good
progresswas noted during the patient’s 26-month follow-up, andthe reconstructed external ear showed excellent esthetic and
structural support (Fig. 4).
3. Discussion
ACC (also called cylindroma in the older literature),
although it seldom arises in the EAC, is the most common
malignant lesion of glandular origin.3,7,8 Our review of 106
cases of ACC arising from the EAC is based on the PubMed
indexed English literature. Of the 106 ACC cases, 93 had
clearly identified gender data, with a female-to-male ratio of
1.58 (57 vs. 36), indicating that females are more prone to
being affected than males. Although ACC may appear at any
age, the peak incidence is around the fourth and fifth decades
of life. This tumor has an indolent clinical course and usually
grows for years before causing symptoms, and thus tends to
result in late diagnosis.
The most common clinical manifestations are otorrhea, pain,
hearing loss, bleeding, and a mass or polyp in the ear canal.9e11
Differential diagnosis of a mass lesion in the EAC includes
adenoma, papilloma, tuberculosis, and other neoplasms such as
mucoepidermoid carcinoma, adenocarcinoma, basal cell carci-
noma, and squamous cell carcinoma. Because of the propensity
of ACC toward aggressive repeated local recurrences and distant
metastases, it is important for clinicians to determine the extent of
tumor invasion for adequate surgical planning and manage-
ment.12 The use ofMRI in cases of ACC of the EAC has not been
fully delineated.13ACCoccurring elsewhere in the head and neck
may show low-signal intensity on T1-weighted (T1w) MRI
images and high or low intensity on T2-weighted (T2w) images,
dependingon its cellularity.Our case presentedwith low intensity
on T1w but high intensity on T2w images, indicating low cellu-
larity, which was compatible with predominantly cribriform
histological features.
Fig. 2. Intraoperative photographs of the lateral temporal bone resection. (A) The operation started with obliteration of the orifice of the external auditory can
(EAC; arrows) to prevent tumor seeding. (B) En bloc surgical removal of the lateral temporal bone along with the tympanic membrane and the ossicles
(arrowhead). (C) The tumor origin was found in the superior and posterior aspects of the EAC (arrows).
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controversial, although it has been proposed that these tumors
may arise from the eccrine sweat glands or ectopic salivary
glands.14 Evidence of origin in the ceruminous glands has also
been demonstrated in recent studies.7 Histologically, ACC can
present in three patterns: tubular, cribriform, and solid.15
Immunohistochemical staining and electron microscopic
examinations have revealed that the tubular pattern contains
the greatest dual differentiation of the ceruminous glands
(ductal and myoepithelial cells), while the solid pattern has the
least. These findings more or less reflect the relationship
between ACC and the ceruminous gland. In addition, it has
been found that when arising from the salivary glands, these
three ACC patterns show a significant correlation between
histological pattern and prognosis,16,17 with the tubular pattern
having the best prognosis. For ACC of the EAC, a correlation
between histopathological status and clinical behavior has yet
to be established. An analysis of the case presented here and
40 cases reported in the literature with clear histological
descriptions revealed that the cribriform pattern has theFig. 3. (A) Micrograph of adenoid cystic carcinoma showing a characteristic crib
(B) The lumina in the cribriform areas contained hyaline material (hematoxylin ahighest prevalence (27 cases, 65.9%), with tubular and solid
features found in 11 (26.8%) and three (7.3%) cases, respec-
tively (Table 1). However, the relationship between histopa-
thology and prognosis remains obscure because of the limited
number of cases and inadequate long-term follow-up. Never-
theless, it is believed that ACC arising in the EAC is far more
aggressive than ACC in the salivary glands and leads to poor
prognosis, in spite of the histological findings. Most authors
have suggested that a solid histological pattern may be highly
associated with the worst prognosis, as observed for ACC of
the salivary glands. Further efforts involving detailed case
studies and more reported cases will be needed to provide
meaningful correlations.
ACC has a propensity towards early perineural involve-
ment, which might explain why otalgia is one of the most
common symptoms. In our review of the literature, the inci-
dence of perineural involvement was estimated at 80% for 35
cases, including the present one, regardless of whether or not
initial perineural invasion was clearly mentioned. Expression
of neural cell adhesion molecules by neoplastic tumor cellsriform pattern with perineural invasion (hematoxylin and eosin stain, 100).
nd eosin stain, 400).
Fig. 4. The patient was monitored and was disease-free for 26 months.
Excellent esthetic results were achieved.
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sion of ACC that accounts for most intracranial involvement
cases.18 When perineural invasion is identified, the tumor
recurrence rate is higher (50% vs. 14.3%). Lymphovascular
invasion is not common; our review revealed only four out of
35 cases (11.4%; Table 1). The tumor recurrence rate is also
higher in lymphovascular invasion (66.7% vs. 23.1%).
In view of its locally aggressive behavior, treatment of ACC
of the EAC depends on complete surgical resection with clear
margins. In our case, the tumor was located just outside the
tympanic annulus without invasion of the middle ear or mastoid
cavities; therefore, lateral temporal bone resection was suitable
as the surgical choice rather than more invasive subtotalTable 1
Summary of the literature review of adenoid cystic carcinoma of the external aud
Reference Patients Histology (n ¼ 41) P
Tubular Cribriform Solid
3 24 5 11 1 1
4 1 1
8 1 1
9 2 1
10 1 1 1
11 1 1
12 1 1
13 1 1
14 16 5 10 1 1
19 10
20 2
This case 1 1 1
Summary 61 11 27 3 2
(26.8%) (65.9%) (7.3%) (8
LVI ¼ lymphovascular invasion; ND ¼ neck dissection; PARO ¼ parotidectomy;temporal bone resection or total temporal bone resection. Apart
from surgical margins, involvement of the parotid gland, nerve,
and bone are also important prognostic factors.19 Elective
parotidectomy is recommended, even for patients in early ACC
stages, because our review revealed an estimated 30% positive
rate in patients with negative clinical parotid gland involvement
preoperatively (12 out of 41 cases underwent parotidectomy).
Metastases to regional lymph nodes and distant sites have been
documented.3,20 In our review, occult lymph node metastasis
was recognized in 11.1% (four out of 36) of cases who under-
went neck dissection (Table 1).
Regarding the role of postoperative radiation therapy in
ACC of the EAC, it is difficult to determine the impact of
postoperative radiation on the outcome of a limited number of
patients. However, on identifying specific tumor factors, Sil-
verman et al suggested that advanced T-stage and positive
microscopic margins are important factors in determining the
necessity for postoperative radiation therapy for ACC of the
head and neck.21 In addition, postoperative radiation is indi-
cated for patients with ACC located in the sinonasal tract,
cervical nodal metastasis, a predominant solid histologic
pattern, perineural invasion, and recurrent tumors.22e25 For
patients with early T-stage tumors and negative surgical
margins, such as in our case, adjuvant radiation therapy may
not be necessary.21 Use of radiotherapy alone yields a low
survival rate.8 A recent study identifying the role of chemo-
therapy in salivary gland ACC showed that there is little
evidence that systemic treatment for ACC alters its course.26
Early diagnosis is still the best option for successful treatment.
In conclusion, ACC is a rare neoplasm originating in the
EAC. The cribriform histological pattern is more predominant
and demonstrates a high perineural invasion rate. Occult
parotid gland involvement should not be overlooked. Delayed
distant metastasis of this neoplasm to the lungs, kidneys, and
vertebrae should be kept in mind. Most postoperative recur-
rences have been reported within 2 years following treatment,
but the interval may extend to up to 15 years.3 Although the 5-
year survival rate is high, owing to the high risk of local
recurrence and delayed distant metastasis, a surgical approachitory canal.
NI (n ¼ 35) LVI (n ¼ 35) PARO (n ¼ 41) ND (n ¼ 36)
5/22 3/22 0/10 1/6
0/1 0/1
0/1
/1 1/1 0/1 0/1
0/1 0/1
1/11 0/11 4/14 2/14
7/10 0/10
1/2 1/2
/1 0/1 0/1 0/1
8 4 12 4
0%) (11.4%) (29.3%) (11.1%)
PNI ¼ perineural invasion.
300 S.-C. Liu et al. / Journal of the Chinese Medical Association 75 (2012) 296e300involving en bloc removal of the tumor with clear margins,
followed by postoperative radiation and close long-term
follow-up, is highly recommended.References
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